MediciBioㅣ메디치바이오

MediciBIO is established with the aim of developing novel gene therapy technology, which will open a new paradigm in the upcoming pharmaceutical area, by converging knowledge and technologies in the fields of new drug development, drug delivery, and genetic biotechnology.

MediciBIO is seeking to develop innovative new drugs for genetic and incurable diseases, and state of the art platform technology for gene therapy through collaboration with research organizations and advisory board. By accomplishing our research projects, MediciBIO aims to continuously create a new market in the field of gene therapy through exporting novel products of platform technology in addition to licensing out our innovative new drugs.

The external goal of MediciBIO is to become a top-notch global firm for gene therapy by implementing a win-win strategy for both our partners and employees. We also drive to make every employee the owner of MediciBIO by maximizing their capacity and creativity and by reasonable compensation including the distribution of profit and stock option.

MediciBIO pursues to become a global leader of gene therapy technology in the genetic market that is expected to expand over the next 30 years. We always value human life and technology, and will put tremendous efforts to thrive through open communication with our partners and customers on the same path.

We appreciate your support and cooperation.

CEO Min-Hyo Ki

MediciBIO is established with the aim of developing novel gene therapy technology, which will open a new paradigm in the upcoming pharmaceutical area, by converging knowledge and technologies in the fields of new drug development, drug delivery, and genetic biotechnology.

MediciBIO is seeking to develop innovative new drugs for genetic and incurable diseases, and state of the art platform technology for gene therapy through collaboration with research organizations and advisory board. By accomplishing our research projects, MediciBIO aims to continuously create a new market in the field of gene therapy through exporting novel products of platform technology in addition to licensing out our innovative new drugs.

The external goal of MediciBIO is to become a global specialty company for gene therapy by implementing a win-win strategy for both our partners and employees. We also drive to make every employee the owner of MediciBIO by maximizing their capacity and creativity and by reasonable compensation including distribution of profit and stock option.

MediciBIO pursues to become a global leader of gene therapy technology in the genetic market that is expected to expand over the next 30 years. We always value human life and technology, and will put tremendous efforts to thrive through open communication with our partners and customers on the same path.

We appreciate your support and cooperation.

CEO Min-Hyo Ki

ABOUT US

MediciBIO values human life and technology, and will put tremendous efforts to thrive through open communication with our partners and customers on the same path.

MediciBIO values human life and technology, and will put tremendous efforts to thrive through open communication with our partners and customers on the same path.